Effects of adrenomedullin 2 on regional hemodynamics in conscious rats

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 128-132

  Fujisawa, Yoshihide ^a   Nagai, Yukiko ^a   Miyatake, Akira ^a   Miura, Katsuyuki ^b   Nishiyama, Akira ^a   Kimura, Shoji ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenomedullin 2; Hemodynamics; Microsphere; Regional

Indexed keywords

HORMONE; INTERMEDIN;

ADRENAL BLOOD FLOW; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CIRCULATION; CONSCIOUSNESS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; HEART OUTPUT; HEART RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; LIVER BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; SPLEEN BLOOD FLOW; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE; VASCULARIZATION; VASODILATATION; WISTAR KYOTO RAT;

ADRENOMEDULLIN; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; MALE; NEUROPEPTIDES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE;

EID: 33847256351     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.043     Document Type: Article

References (20)

1. Brain S.D., Andrew D., and Grant A.D. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol. Rev. 84 (2004) 903-934
2. DiPette D.J., Sshwarzenberger K., and Kerr N. Systemic and regional hemodynamic effects of calcitonin gene-related peptide. Hypertension 9 Suppl. III (1987) III142-III146
3. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 22 (2001) 1693-1711
4. Franco-Cereceda A., and Lundberg J.M. Calcitonin gene-related peptide (CGRP) and capsaicin-induced stimulation of heart contractile rate and force. Naunyn-Schmiedebergs Arch. Pharmakol. 331 (1985) 146-151
5. Fujisawa Y., Nagai Y., Miyatake A., Takei Y., Miura K., Shoukouji T., Nishiyama A., Kimura S., and Abe Y. Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats. Eur. J. Pharmacol. 497 (2004) 75-80
6. Fujisawa Y., Nagai Y., Miyatake A., Miura K., Shokoji T., Nishiyama A., Kimura S., and Abe Y. Roles of adrenomedullin2 in regulating the cardiovascular and sympathetic nervous systems in conscious rats. Am. J. Physiol., Heart Circ. Physiol. 290 (2005) H1120-H1127
7. Gennari C., and Fischer J.A. Cardiovascular action of calcitonin gene-related peptide in humans. Calcif. Tissue Int. 37 (1985) 581-584
8. He H., Bessho H., Fujisawa Y., Horiuchi K., Tomohiro A., Kita T., Aki Y., Kimura S., Tamaki T., and Abe Y. Effects of a synthetic rat adrenomedullin on regional hemodynamics in rats. Eur. J. Pharmacol. 273 (1995) 209-214
9. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 21 (2000) 138-167
10. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., and Eto T. Distribution and characterization of immunoreactive adrenomedullin in porcine tissue, and isolation of adrenomedullin [26-52] and adrenomedullin [34-52] from porcine duodenum. J. Biochem. (Tokyo) 118 (1995) 765-770
11. Ishimitsu T., Nishikimi T., Saito Y., Kitamura K., Eto T., Kangawa K., Matsuo H., Omae T., and Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. 94 (1994) 2158-2161
12. Jougasaki M., Wei C.M., McKinley L.J., and Burnett Jr. J.C. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92 (1995) 286-289
13. Nagae T., Mukoyama M., Sugawara A., Mori K., Yahata K., Kasahara M., Suganami T., Makino H., Fujinaga Y., Yoshioka T., Tanaka I., and Nakao K. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: cloning and upregulation in obstructive nephropathy. Biochem. Biophys. Res. Commun. 270 (2000) 89-93
14. Roh J., Chang C.L., Bhalla A., Klein C., and Hsu S.Y. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J. Biol. Chem. 279 (2004) 7264-7274
15. Sakata J., Shimokubo T., Kitamura K., Nishizono M., Iehiki Y., Kangawa K., Matsuo H., and Eto T. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352 (1994) 105-108
16. Takei Y., Inoue K., Ogoshi M., Kawahara T., Bannai H., and Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett. 556 (2004) 53-58
17. Taylor M.M., Bagley S.L., and Samson W.K. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Am. J. Physiol., Regul. Integr. Comp. Physiol. 288 (2005) R919-R927
18. Tomohiro A., Kimura S., He H., Fujisawa Y., Nishiyama A., Kiyomoto K., Aki Y., Tamaki T., and Abe Y. Regional blood flow in Dahl-Iwai salt-sensitive rats and the effects of dietary l-arginine supplementation. Am. J. Physiol. 272 (1997) R1013-R1019
19. Yang J.H., Jia Y.X., Pan C.S., Zhao J., Ouyang M., Yang J., Chang J.K., Tang C.S., and Qi Y.F. Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem. Biophys. Res. Commun. 327 (2005) 713-719
20. Yang J.H., Qi Y.F., Jia Y.X., Pan C.S., Zhao J., Yang J., Chang J.K., and Tang C.S. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts. Peptides 26 (2005) 501-507